Back
Edgewise Therapeutics Stock Price Chart
Sponsored
EWTX
Sponsored
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Buy
58
EWTX
Edgewise Therapeutics
Last Price:
33.12
Seasonality Move:
66.43%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- The current trend is moderately bearish and EWTX is experiencing selling pressure, which indicates risk of future bearish movement.
Edgewise Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.33 | Sell |
20-day SMA: | 34.81 | Sell |
50-day SMA: | 28.58 | Buy |
200-day SMA: | 20.64 | Buy |
8-day EMA: | 34.86 | Sell |
20-day EMA: | 33.9 | Sell |
50-day EMA: | 29.89 | Buy |
200-day EMA: | 21.31 | Buy |
Edgewise Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.64 | Buy |
Relative Strength Index (14 RSI): | 50.79 | Buy |
Chaikin Money Flow: | -550609 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.47 - 35.79) | Sell |
Bollinger Bands (100): | (16.95 - 30.63) | Buy |
Edgewise Therapeutics Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Edgewise Therapeutics Stock
Is Edgewise Therapeutics Stock a Buy?
- Edgewise Therapeutics share price is 33.26 while EWTX 8-day simple moving average is 35.33, which is a Sell signal.
- The stock price of EWTX is 33.26 while Edgewise Therapeutics 20-day SMA is 34.81, which makes it a Sell.
- Edgewise Therapeutics 50-day simple moving average is 28.58 while EWTX share price is 33.26, making it a Buy technically.
- EWTX stock price is 33.26 and Edgewise Therapeutics 200-day simple moving average is 20.64, creating a Buy signal.
EWTX Technical Analysis vs Fundamental Analysis
Buy
58
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy or a Sell?
-
Edgewise Therapeutics stock is rated a Buy
The current Edgewise Therapeutics [EWTX] share price is $33.26. The Score for EWTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Edgewise Therapeutics Stock Info
Market Cap:
3.12B
Price in USD:
33.26
Share Volume:
676.74K
Edgewise Therapeutics 52-Week Range
52-Week High:
38.12
52-Week Low:
5.93
Buy
58
Edgewise Therapeutics (EWTX)
is a Buy
Edgewise Therapeutics Share Price Forecast
-
What is the Edgewise Therapeutics stock price today?
The Edgewise Therapeutics stock price is 33.26 USD today. -
Will EWTX stock go up or go down?
Edgewise Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Edgewise Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Edgewise Therapeutics is not overvalued.
Is Edgewise Therapeutics Stock a Buy?
- Edgewise Therapeutics share price is 33.26 while EWTX 8-day exponential moving average is 34.86, which is a Sell signal.
- The stock price of EWTX is 33.26 while Edgewise Therapeutics 20-day EMA is 33.90, which makes it a Sell.
- Edgewise Therapeutics 50-day exponential moving average is 29.89 while EWTX share price is 33.26, making it a Buy technically.
- EWTX stock price is 33.26 and Edgewise Therapeutics 200-day simple moving average is 21.31, creating a Buy signal.
Fundamental Analysis of Edgewise Therapeutics
Is Edgewise Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and a decrease next year of $0.35 per share.
Technical Analysis of Edgewise Therapeutics
Should I short Edgewise Therapeutics stock?
- EWTX Moving Average Covergence Divergence (MACD) indicator is 1.64, suggesting Edgewise Therapeutics is a Buy
- Edgewise Therapeutics Relative Strength Index (RSI) is 50.79, which suggest Edgewise Therapeutics is overbought
- The Bollinger Bands (25) for Edgewise Therapeutics is (32.47 - 35.79), which suggest Edgewise Therapeutics is a Buy
- The Bollinger Bands (100) for Edgewise Therapeutics is (16.95 - 30.63), which suggest Edgewise Therapeutics is a Buy
* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.